awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51779283-994E2D4A-9A6F-4FBD-86EB-044ABEED1F4C
Q51779283-994E2D4A-9A6F-4FBD-86EB-044ABEED1F4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51779283-994E2D4A-9A6F-4FBD-86EB-044ABEED1F4C
Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
P2860
Q51779283-994E2D4A-9A6F-4FBD-86EB-044ABEED1F4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51779283-994E2D4A-9A6F-4FBD-86EB-044ABEED1F4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
acb5d2fad2487153f8a0485a9b9d5ae11cbc944a
P2860
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer